Randomized phase II study of the neurokinin 1 receptor antagonist CJ-11,974 in the control of cisplatin-induced emesis. - Hesketh PJ; Gralla RJ; Webb RT; Ueno W; DelPrete S; Bachinsky ME; Dirlam NL; Stack CB; Silberman SL (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999)